Ventum Financial Cuts WELL Health Technologies (TSE:WELL) Price Target to C$7.00

WELL Health Technologies (TSE:WELLFree Report) had its price objective trimmed by Ventum Financial from C$8.00 to C$7.00 in a research report report published on Tuesday morning, BayStreet.CA reports. The firm currently has a buy rating on the stock.

Separately, CIBC increased their target price on shares of WELL Health Technologies from C$4.75 to C$5.00 in a research note on Friday, August 16th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat, WELL Health Technologies currently has an average rating of “Moderate Buy” and a consensus price target of C$6.97.

View Our Latest Report on WELL

WELL Health Technologies Stock Performance

Shares of WELL stock opened at C$4.39 on Tuesday. The stock’s 50-day moving average is C$4.43 and its two-hundred day moving average is C$4.29. The company has a debt-to-equity ratio of 41.57, a quick ratio of 1.02 and a current ratio of 1.25. WELL Health Technologies has a 1 year low of C$3.41 and a 1 year high of C$5.05. The firm has a market cap of C$1.09 billion, a price-to-earnings ratio of 7.70, a PEG ratio of -1.93 and a beta of 1.20.

WELL Health Technologies Company Profile

(Get Free Report)

WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.

See Also

Analyst Recommendations for WELL Health Technologies (TSE:WELL)

Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.